Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study
暂无分享,去创建一个
D. Amadori | D. Dearnaley | M. Climent | E. Gallardo | A. González del Alba | B. Mellado | F. Demichelis | V. Conteduca | A. Romanel | A. Font | U. de Giorgi | I. Durán | D. Castellano | O. Fernández-Calvo | G. Gurioli | S. Salvi | D. Gasi Tandefelt | G. Attard | E. Grande | E. Gonzalez-Billalabeitia | U. Giorgi | V. Casadio | C. Lolli | J. Puente | D. Wetterskog | S. Vázquez-Estévez | M. Méndez-Vidal | A. Jayaram | A. G. D. Alba | M. P. Fernández-Pérez | A. Rodríguez | A. Wingate | M. Sáez | M. Sharabiani | A. Rodríguez | C. Santander | E. González-Billalabeitia | M. Sáez | A. Rodríguez | Antoni Font | Armando Rodriguez | D. G. Tandefelt | M. Fernández-Pérez